Motavizumab Administration for a Second Season for RSV Prophylaxis Clinical Trials

Motavizumab Administration for a Second Season for RSV Prophylaxis

Explore clinical trials studying Motavizumab Administration for a Second Season for RSV Prophylaxis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Motavizumab Administration for a Second Season for RSV Prophylaxis trial results

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children

NCT00113490

Conditions: Motavizumab Administration for a Second Season for RSV Prophylaxis
Locations: Pontificia Universidade Catolica Do Rio Grande Porto Alegre, Brazil

Hospital Das Clinicas Da Faculdade Ribeirão Preto, Brazil

Hospital Clinico De La Pointificia Universidad Santiago, Chile

Hospital Clinico de la Universidad de Chile Santiago, Chile

View Trial Details